Apogee Therapeutics, Inc. APGE Cash Flow Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| -$255.84M-40.5% | -$182.15M-117% | -$83.99M-10.5% | ||
| $1.41M+648% | $189K— | —— | ||
| $46.28M+98.3% | $23.33M+282% | $6.1M— | ||
| -$227.45M-32.9% | -$171.17M-129% | -$74.76M— | ||
| $5.15M+346% | $1.15M+590% | $167K— | ||
| -$179.57M— | —— | —— | ||
| $396.49M-19.9% | $495.26M— | —— | ||
| —— | —— | -$33.28M— | ||
| -$232.6M-35.0% | -$172.33M-130% | -$74.93M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Apogee Therapeutics, Inc. generate?
- Apogee Therapeutics, Inc. (APGE) generated -$234.5M in operating cash flow over the trailing twelve months.
- What is Apogee Therapeutics, Inc.'s free cash flow?
- After $5.1M of capital expenditures, Apogee Therapeutics, Inc.'s free cash flow was -$232.6M over the trailing twelve months, down 35.0% year over year.
- Where does Apogee Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Apogee Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.